That spells credibility and reads liek a who's who!
Management Team
VolitionRx has put together a proven team that provides exemplary leadership backed by a unique blend of scientific management and business expertise.
Cameron Reynolds - President & Chief Executive Officer
Cameron Reynolds has more than 17 years of entrepreneurial executive expertise in mining and biotechnology companies. He has strong experience in the management, structuring and strategic planning of start-up companies, as well as in securing financing.
Malcolm Lewin - Chief Financial Officer & Treasurer
Malcolm Lewin has a strong background in finance and accounting both for public and private companies alike. He qualified as a chartered accountant with Coopers & Lybrand in 1976. Lewin’s background includes finance director of several companies with interests worldwide.
Jason Terrell MD - Chief Medical Officer & Head of U.S. Operations
Dr. Jason Terrell has a strong grounding in both medicine and more specifically in diagnostics. He currently owns and operates multiple diagnostic laboratories in Texas within the Any Lab Test Now franchise, and has also served as a National Franchise Corporate Medical Director for Any Lab Test Now, giving him oversight of more than 70 franchises in 14 states. Dr. Terrell holds medical licenses in 14 states across the U.S.
Rod Rootsaert - Secretary
Rodney Rootsaert has more than six years of experience in providing corporate, legal and administrative services to start-up companies through Mining House Ltd., of which Rootsaert has been a director since 2007.
Thomas Bygott - Sales & Marketing Director
Tom Bygott is a qualified bioinformatician with more than 12 years of experience in sales and marketing for technology companies. Bygott started his career with the Australian electronics company AWA as a business analyst conducting reviews of their Traffic division and electronics factory, later becoming a Marketing Executive for their Aerospace division.
Scientific Executives
Jake Micallef PhD MBA - Chief Scientific Officer, Belgian Volition
Dr. Jacob Micallef has 20 years of experience in research and development and in the management of early stage biotechnical companies, including the manufacture of biotechnology products and the establishment of manufacturing operations. Dr. Micallef gained this experience while working for the World Health Organization (WHO) over a 10-year period from 1985.
Mark Eccleston, PhD - Chief Scientific Officer, HyperGenomics
Dr. Mark Eccleston is a biotechnology entrepreneur with more than 18 years of experience in the sector, both in academia and in industry. His career includes experience from various roles, including a program management position, CEO, chief scientific officer and consultant.
Recent VNRX News
- U.S. Index Futures on the Rise, Oil Prices Show Stability • IH Market News • 03/26/2024 11:21:42 AM
- VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update • PR Newswire (US) • 03/25/2024 08:10:00 PM
- VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update • PR Newswire (US) • 03/21/2024 12:30:00 PM
- Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan • PR Newswire (US) • 03/20/2024 12:30:00 PM
- Volition appoints Dr Andrew Retter as Chief Medical Officer • PR Newswire (US) • 03/19/2024 08:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:05:45 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/09/2024 08:56:57 PM
- Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar • PR Newswire (US) • 02/02/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:05:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:05:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:05:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:04:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:04:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:04:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:04:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:04:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:04:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:03:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:03:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:02:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:02:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:02:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:01:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:01:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:01:19 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM